当前位置: X-MOL 学术J. Hepatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Liver cancer in 2021: Global burden of disease study
Journal of Hepatology ( IF 26.8 ) Pub Date : 2024-10-30 , DOI: 10.1016/j.jhep.2024.10.031
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, Zhenning Yu, Darren Jun Hao Tan, Wen Hui Lim, Benjamin Koh, Ryan Yan Zhe Lim, Ethan Kai Jun Tham, Kartik Mitra, Asahiro Morishita, Yao-Chun Hsu, Ju Dong Yang, Hirokazu Takahashi, Ming-Hua Zheng, Atsushi Nakajima, Cheng Han Ng, Karn Wijarnpreecha, Mark D. Muthiah, Amit G. Singal, Daniel Q. Huang

The epidemiology of adult primary liver cancer continues to evolve, owing to the increasing prevalence of metabolic disease, rising alcohol consumption, advances in vaccination for HBV, and antiviral therapy for HCV. Disparities in care and the burden of liver cancer between populations persist. We assess trends in the burden of liver cancer and contributions by various etiologies across 204 countries and territories from 2010 to 2021.

中文翻译:


2021 年肝癌:全球疾病负担研究



由于代谢性疾病患病率的增加、饮酒量的增加、HBV 疫苗接种的进步以及 HCV 抗病毒治疗的进步,成人原发性肝癌的流行病学不断发展。人群之间在护理和肝癌负担方面的差异仍然存在。我们评估了 2010 年至 2021 年期间 204 个国家和地区肝癌负担的趋势和各种病因的贡献。
更新日期:2024-10-30
down
wechat
bug